• 146,382+ Medical Conferences
  • 284 Specialties
  • 10,917 Organizers
  • 154,725 Speakers
  • 156 Countries
  • 4,682 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  James David Brandt
James David Brandt

James David Brandt

Vice Chair, Director, Professor | Sacramento, California    United States of America
Ophthalmology, Glaucoma,...More
Spoken at 2 events
Speaking at 1 event

Biography :

Dr. Brandt has research interests in both the clinical and basic realms. In clinical research, he is a principal investigator in the landmark Ocular Hypertension Treatment Study and was largely responsible for one of the Study's most important findings to date, that thin corneal thickness is a risk factor for the development of glaucoma.

Dr. Brandt is actively involved in large clinical trials investigating new medical and surgical treatments of glaucoma and new technologies for diagnosing the disease. In the basic research arena, Dr. Brandt is currently collaborating with Dr. Tingrui Pan of the Department of Biomedical Engineering to develop new MEMS and Nanotechnology-based devices for the diagnosis of glaucoma.

For speaker's contact information - Contact us



Interested Topics

Ophthalmology, Glaucoma, Ocular Hypertension, General Surgery, Opthalmalmic Pharmacology

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Conference Session Materials

The conference session material has yet to be added by the speaker.

Send Message